Dr. Julio Hajdenberg, MD

Clinical Trials

• Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
• 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

Media Releases

Get to know Hematologist-Oncologist Dr. Julio Hajdenberg, who serves patients throughout the State of Massachusetts. 

A triple board-certified hematologist-oncologist, Dr. Hajdenberg is on the Faculty of Hematology and Oncology at VA Boston Healthcare System.

In his current position, he is leveraging his prior experience as a clinician and clinical investigator in cancer and blood disorders. 

Prior to moving to Massachusetts, Dr. Hajdenberg has had the opportunity to invent a cell phone-based hand hygiene monitoring device (Hygiene-Fi); co-founded Consystent AI, a small startup that explores the potential medical uses of socially assistive robots (SAR): the Betty project; and to collaborate with local entrepreneurs, the Mixed Emerging Technology Integration Lab at UCF’s Institute for Simulation and Training, and at the University of Florida.

Back in the early days of his academic career, Dr. Hajdenberg graduated with his medical degree from the Faculty of Medical Sciences of the University of Buenos Aires in 1990. He then went on to perform his residency in internal medicine at Cooper University Hospital, and his fellowship in hematology and medical oncology at Beth Israel Deaconess Medical Center. 

Board-certified in internal medicine, hematology, and medical oncology, the doctor is a Diplomate of the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

As a clinician, Dr. Hajdenberg is proud of his immediate prior work of 17 years at MD Anderson Cancer Center Orlando as Department Chair, where they built a best in class clinical practice, a fellowship training program, a clinical research program, a quality program, and a stem cell transplant program. 

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

Among Dr. Hajdenberg’s various accolades include Patients’ Choice Award (2014, 2013, 2012, 2011, 2010), Compassionate Doctor Recognition (2014, 2013, 2012, 2011, 2010), On-Time Doctor Award (2014), Patients’ Choice 5th Anniversary Award (2014), Compassionate Doctor Award – 5 Year Honoree (2014), and Top 10 Doctor – Metro Area (2014).

On a more personal note, he speaks both English and Spanish.

Recommended Articles

• The Blow Self-Image Can Take During Lymphoma Treatment

  Many who have endured cancer treatment experience a blow to their self image, and cease to recognize the person looking back at them in the mirror.However, it does not have to be that way! Here are some of the most common changes, and how to cope with them.Skin changesYou may begin to see your skin...

• 9/11 Ground Zero Worker's Lymphoma Improves with Clinical Trial

  When the terrorist attacks occurred in New York on September 11th, 2001, Bart Zagami, a 61-year-old New York State Supreme Court officer, was in his office just a few blocks away from the World Trade Center in lower Manhattan. Days after the 9/11 terrorist attacks, Zagami spent his time at Ground...

• The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer

  On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...

• Facts About Multiple Myeloma

  Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...

• Black Sabbath's Tony Iommi Discusses Struggles with Lymphoma

  Tony Iommi is one of the few rock and roll legends who can say that they fulfilled the industry’s cliché act of getting the band back together. In 2011, the loss of a good friend brought the Black Sabbath guitarist Iommi back into contact with the band’s original lead vocalist, Ozzy Osbourne....

• Promising Results for Hodgkin Patients Using This Therapy

  Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...